Naishuo Zhu

Title: Naishuo Zhu: Innovator in Peptide Therapeutics

Introduction

Naishuo Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of peptide therapeutics, focusing on innovative solutions for treating inflammatory and autoimmune diseases. With a total of 3 patents, his work is paving the way for new medical advancements.

Latest Patents

One of Naishuo Zhu's latest patents is titled "High-affinity peptide for tumor necrosis factor alpha and application thereof." This invention describes a peptide with a high binding affinity for tumor necrosis factor alpha (TNF-α). The peptide can significantly reduce inflammation in animal bodies and improve resistance to inflammatory damage. It has a wide application prospect for developing TNF-α antagonist drugs for various acute and chronic inflammatory conditions.

Another notable patent is "Peptide having high affinity for PD-L1 protein and use thereof." This invention provides a peptide that can bind to human PD-L1 with high affinity. It competitively blocks the PD-1/PD-L1 interaction, thereby activating immunity and enhancing T cell lethality against tumor cells. These innovations highlight Zhu's commitment to advancing therapeutic options in oncology and immunology.

Career Highlights

Naishuo Zhu has worked at Fudan University, where he has contributed to research and development in peptide therapeutics. His academic background and research experience have equipped him with the knowledge and skills necessary to innovate in this critical field.

Collaborations

Throughout his career, Naishuo Zhu has collaborated with notable colleagues, including Changwu Hu and Baoxiu Liu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Naishuo Zhu's work in peptide therapeutics represents a significant advancement in the treatment of inflammatory and autoimmune diseases. His innovative patents and collaborations position him as a key figure in the ongoing development of effective medical therapies.